-
Mashup Score: 0Patient Information: What Is Cirrhosis? - 9 month(s) ago
This JAMA Patient Page describes liver cirrhosis, its signs and symptoms, potential complications, and treatment options.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis - 10 month(s) ago
Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data presented at EASL Congress.“Rifaximin prevents recurrent hepatic encephalopathy; however, it is not known whether it may have beneficial effects on other complications of cirrhosis,” Elisa
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
Use of #simvastatin plus #rifaximin not supported in #patients with decompensated #cirrhosis #EASLCongress #LiverTwitter #MedTwitter https://t.co/Z24LzDDlFq
-
-
Mashup Score: 0Safety Considerations With OCA in PBC - 10 month(s) ago
Experts in hepatology discuss safety considerations for use of OCA in patients with cirrhosis and decompensated cirrhosis.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In this video, our panels of experts in #hepatology discuss safety considerations for use of obeticholic acid in patients with decompensated #cirrhosis. https://t.co/06Wgly3Pkt https://t.co/y5d7SVsy9s
-
-
Mashup Score: 0Use of simvastatin plus rifaximin not supported in patients with decompensated cirrhosis - 10 month(s) ago
Simvastatin plus rifaximin did not reduce progression to acute-on-chronic liver failure, complications from cirrhosis or risk for death in patients with decompensated cirrhosis, according to data presented at EASL Congress.“Rifaximin prevents recurrent hepatic encephalopathy; however, it is not known whether it may have beneficial effects on other complications of cirrhosis,” Elisa
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Simvastatin plus #rifaximin did not reduce progression to acute-on-chronic #liverfailure, complications from cirrhosis or risk for death in #patients with decompensated #cirrhosis, according to data presented at #EASLCongress @EASLNews https://t.co/Z24LzDDlFq
-
-
Mashup Score: 0Only 25% of patients with cirrhosis receive transplant referrals at safety-net hospitals - 10 month(s) ago
Nearly 75% of patients with end-stage liver disease in safety-net hospitals were not referred for liver transplant evaluation, mostly due to active alcohol use or insurance issues, according to data published in JAMA Network Open. “Patients with cirrhosis treated at safety-net hospitals have high mortality,” Mignote Yilma, MD, of the department of general surgery at the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from @JAMANetworkOpen: Only 25% of #patients with #cirrhosis receive #transplant referrals at safety-net hospitals #LiverTwitter #MedTwitter https://t.co/M8JhKD7JD2
-
-
Mashup Score: 2Xarelto boosts survival for portal hypertension in cirrhosis without hike in bleeding risk - 10 month(s) ago
Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at the EASL Congress.“Observational studies and a non-double-blind, non-placebo randomized study suggested that anticoagulation decreases the probability of developing portal hypertension
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Xarelto boosts survival for #portalhypertension in #cirrhosis without hike in bleeding risk #EASLCongress #LiverTwitter #MedTwitter @EASLnews https://t.co/PRX5RTnkdt
-
-
Mashup Score: 9Patient Information: What Is Cirrhosis? - 10 month(s) ago
This JAMA Patient Page describes liver cirrhosis, its signs and symptoms, potential complications, and treatment options.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Cirrhosis occurs when scar tissue replaces normal liver tissue, causing permanent liver damage. This JAMA Patient Page describes #cirrhosis, its signs and symptoms, potential complications, and treatment options. https://t.co/ty7jhNFlO6 https://t.co/k3htHeTGIe
-
-
Mashup Score: 0Xarelto boosts survival for portal hypertension in cirrhosis without hike in bleeding risk - 10 month(s) ago
Xarelto improved portal hypertension complication-free survival in patients with cirrhosis and moderate liver dysfunction without an increase in major bleeding events, according to data presented at the EASL Congress.“Observational studies and a non-double-blind, non-placebo randomized study suggested that anticoagulation decreases the probability of developing portal hypertension
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Xarelto improved #portalhypertension complication-free survival in #patients with #cirrhosis and moderate #liverdysfunction without an increase in major bleeding events, according to data presented at the #EASLCongress. @EASLnews https://t.co/PRX5RTnkdt
-
-
Mashup Score: 0Fecal Matter Transplant Shows Promise in Cirrhosis - 10 month(s) ago
Pilot trial demonstrates that FMT can boost gut health, prevent serious infections
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
"If you look who is the closest friend of the gut, that's the liver." -- @AleksanderKrag, of @OUHhospital, discussing fecal microbiota transplants in patients with #cirrhosis. @EASLnews https://t.co/UE6NK3gCyt
-
-
Mashup Score: 0
Fecal microbiota transplantation improved gut barrier function, mucosal immunity and ammonia metabolism in patients with cirrhosis, which could reduce hepatic encephalopathy and other infections, according to data from the PROFIT trial. “Patients with cirrhosis have enteric dysbiosis,” Lindsey A. Edwards, BSC, MSc, PhD, research director of fecal microbiota transplant program at
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #EASLCongress: #FMT shows promise in restoring #gutbarrier function, immunity in #cirrhosis #EASL23 @EASLnews https://t.co/qHzXL6b78T
-
Cirrhosis occurs when scar tissue replaces normal liver tissue, causing permanent liver damage. This JAMA Patient Page describes #cirrhosis, its signs and symptoms, potential complications, and treatment options. https://t.co/w9P8tAtQmW https://t.co/DEkFXFbRAB